Evidence map›Paper›PMID 29386252›Full record

ArticleJournal of medical genetics2018

Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes

Katrina A Andrews, David B Ascher, Douglas Eduardo Valente Pires, Daniel R Barnes, Lindsey Vialard, Ruth T Casey, Nicola Bradshaw, Julian Adlard, Simon Aylwin, Paul Brennan and 27 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 134 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 6 pooled it
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 6 syntheses or guidelines pooled it, 246 citations in OpenAlex.

  1. Clinical characteristics and prognosis ofJournal of medical genetics · 2026
    Pooled it
  2. Guideline
  3. Outcomes of SDHB Pathogenic Variant Carriers.The Journal of clinical endocrinology and metabolism · 2024
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Tumor risks and surveillance outcomes inEndocrine oncology (Bristol, England) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 19 institutions in 3 countries.

Katrina A AndrewsDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Cancer Centre and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
David B AscherDepartment of Biochemistry, University of Cambridge, Cambridge, UK.
Douglas Eduardo Valente PiresDepartment of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3004-2119
Daniel R BarnesDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Lindsey VialardWest Midlands Regional Genetics service, Birmingham Women's Hospital, Birmingham, UK.
Ruth T CaseyDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Cancer Centre and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Nicola BradshawDepartment of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, UK.
Julian AdlardYorkshire Regional Genetics Service, St. James's University Hospital, Leeds, UK.
Simon AylwinDepartment of Endocrinology, King's College Hospital, London, UK.
Paul BrennanNorthern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Carole BrewerPeninsula Clinical Genetics Service, Royal Devon & Exeter Hospital, Exeter, UK.
Trevor ColeWest Midlands Regional Genetics service, Birmingham Women's Hospital, Birmingham, UK.
Jackie A CookDepartment of Clinical Genetics, Sheffield Children's Hospital, Sheffield, UK.
Rosemarie DavidsonDepartment of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, UK.
Alan DonaldsonDepartment of Clinical Genetics, St Michael's Hospital, Bristol, UK.
Alan FryerDepartment of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
Lynn GreenhalghDepartment of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
Shirley V HodgsonDepartment of Medical Genetics, St. George's University of London, London, UK.
Richard IrvingQueen Elizabeth Medical Centre, Queen Elizabeth Hospital, Birmingham, UK.
Fiona LallooManchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Michelle McConachieEast of Scotland Regional Genetics Service, Ninewells Hospital and Medical School, Dundee, UK.
Vivienne P M McConnellNorthern Ireland Regional Genetics Service, Belfast City Hospital, Belfast Health & Social Care Trust, Belfast, UK.
Patrick J MorrisonNorthern Ireland Regional Genetics Service, Belfast City Hospital, Belfast Health & Social Care Trust, Belfast, UK.
Victoria MurdayDepartment of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, UK.
Soo-Mi ParkDepartment of Clinical Genetics, Addenbrooke's Treatment Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Helen L SimpsonThe Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Katie SnapeDepartment of Medical Genetics, St. George's University of London, London, UK.
Susan StewartWest Midlands Regional Genetics service, Birmingham Women's Hospital, Birmingham, UK.
Susan E TomkinsDepartment of Clinical Genetics, St Michael's Hospital, Bristol, UK.
Yvonne WallisWest Midlands Regional Genetics service, Birmingham Women's Hospital, Birmingham, UK.
Louise IzattDepartment of Clinical Genetics, Guy's Hospital, London, UK.
David GoudieEast of Scotland Regional Genetics Service, Ninewells Hospital and Medical School, Dundee, UK.
Robert S LindsayInstitute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, Scotland.
Colin G PerryInstitute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, Scotland.
Emma R WoodwardManchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Antonis C AntoniouDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Eamonn R MaherDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Cancer Centre and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0002-6226-6918
University of Cambridge · GBBirmingham Women's Hospital · GBQueen Elizabeth University Hospital · GBBelfast Health and Social Care Trust · GBCambridge University Hospitals NHS Foundation Trust · GBNinewells Hospital · GBSt George's, University of London · GBSt Mary's Hospital · GBSt Michael's Hospital · GBUniversity of Glasgow · GBUniversity of Liverpool · GBGuy's Hospital · GBKing's College Hospital · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBQueen Elizabeth Hospital Birmingham · GBRoyal Devon and Exeter Hospital · GBSheffield Children's Hospital · GBSt James's University Hospital · GBThe University of Melbourne · AU

Funding

British Heart Foundation PG/12/7/29365Cancer Research UK 20861Cancer Research UK C12292/A20861
6 · The paper itself

Abstract

backgroundGermline pathogenic variants in

methodsA retrospective survey of 1832 individuals referred for genetic testing due to a personal or family history of phaeochromocytoma/paraganglioma. 876 patients (401 previously reported) had a germline mutation in

resultsTumour risks analysis provided novel penetrance estimates and genotype-phenotype correlations. In addition to tumour type susceptibility differences for individual genes, we confirmed that the

conclusionsOverall risks of clinically apparent tumours for

Indexed as

Adrenal Gland NeoplasmsAgedAged, 80 and overAge FactorsFemaleGenetic Association StudiesGenotypeGerm-Line MutationHeterozygoteHumansKaplan-Meier EstimateMaleMembrane ProteinsMiddle AgedMutation, MissenseParagangliomaMembrane ProteinsSDHB protein, humanSDHC protein, humanSDHD protein, humanSuccinate Dehydrogenasecancer: endocrinegenetic epidemiologygeneticsmolecular geneticsoncology

Identifiers

PMID29386252
PMCPMC5992372
OpenAlexW2787839563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.